BioCentury
ARTICLE | Politics & Policy

C-Path, IMI consortia in biomarkers deal

May 25, 2013 12:53 AM UTC

Consortia led by the Critical Path Institute and Europe's Innovative Medicines Initiative (IMI) partnered to develop new biomarkers to predict, diagnose and monitor drug-induced injury to the liver, k...